Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Specimen Handling 149pembrolizumab 131Cyclophosphamide 118Magnetic Resonance Spectroscopy 117Biopsy 105fludarabine 89Nivolumab 62Carboplatin 54Cisplatin 49Gemcitabine 48Radiotherapy 47venetoclax 45Paclitaxel 43Cetuximab 40fludarabine phosphate 39Ipilimumab 37Fluorouracil 36atezolizumab 33Bevacizumab 33durvalumab 31Oxaliplatin 29X-Rays 28Leucovorin 28Dexamethasone 28Radiation 27Irinotecan 27Cytarabine 26Azacitidine 26Injections 24Radiosurgery 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Clomiphene × 90 days × Clear all
NCT06813118 2026-05-07

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

HITEC-Institute of Medical Sciences

Phase 1 Completed
42 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡